BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 15331693)

  • 1. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
    Abe Y; Takashita E; Sugawara K; Matsuzaki Y; Muraki Y; Hongo S
    J Virol; 2004 Sep; 78(18):9605-11. PubMed ID: 15331693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
    Igarashi M; Ito K; Kida H; Takada A
    Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of individual oligosaccharide chains in antigenic properties, intracellular transport, and biological activities of influenza C virus hemagglutinin-esterase protein.
    Sugahara K; Hongo S; Sugawara K; Li ZN; Tsuchiya E; Muraki Y; Matsuzaki Y; Nakamura K
    Virology; 2001 Jun; 285(1):153-64. PubMed ID: 11414815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.
    Matrosovich MN; Gambaryan AS; Teneberg S; Piskarev VE; Yamnikova SS; Lvov DK; Robertson JS; Karlsson KA
    Virology; 1997 Jun; 233(1):224-34. PubMed ID: 9201232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses.
    Lee MS; Chen MC; Liao YC; Hsiung CA
    Vaccine; 2007 Nov; 25(48):8133-9. PubMed ID: 17950961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
    Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
    Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of human convalescent sera with influenza virus hemagglutinin protein mutants at antigenic site A.
    Nobusawa E; Omagari K; Nakajima S; Nakajima K
    Microbiol Immunol; 2012 Feb; 56(2):99-106. PubMed ID: 22309642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells.
    Owen RE; Yamada E; Thompson CI; Phillipson LJ; Thompson C; Taylor E; Zambon M; Osborn HM; Barclay WS; Borrow P
    J Virol; 2007 Oct; 81(20):11170-8. PubMed ID: 17670834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides.
    Nobusawa E; Ishihara H; Morishita T; Sato K; Nakajima K
    Virology; 2000 Dec; 278(2):587-96. PubMed ID: 11118381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.
    Ilyushina N; Rudneva I; Gambaryan A; Bovin N; Kaverin N
    Virology; 2004 Nov; 329(1):33-9. PubMed ID: 15476872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the structure of influenza B hemagglutinin using site-directed mutagenesis.
    Rivera K; Thomas H; Zhang H; Bossart-Whitaker P; Wei X; Air GM
    Virology; 1995 Feb; 206(2):787-95. PubMed ID: 7856092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99.
    Jin H; Zhou H; Liu H; Chan W; Adhikary L; Mahmood K; Lee MS; Kemble G
    Virology; 2005 May; 336(1):113-9. PubMed ID: 15866076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs.
    Chen Z; Aspelund A; Jin H
    Vaccine; 2008 Jan; 26(3):361-71. PubMed ID: 18079027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
    Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
    J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting antigenic variants of influenza A/H3N2 viruses.
    Lee MS; Chen JS
    Emerg Infect Dis; 2004 Aug; 10(8):1385-90. PubMed ID: 15496238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice.
    Tate MD; Brooks AG; Reading PC
    J Immunol; 2011 Aug; 187(4):1884-94. PubMed ID: 21768397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.